Bioventus Inc. - Class A Stock (BVS)

CUSIP: 09075A108

Q1 2022 13F Holders as of 31 Mar 2022

Holder snapshot 6 signals
Share change
+525,851
SEC-reported price per share
$14.10
Number of holders
100
Value change
+$7,048,976
Number of buys
48
Number of sells
52
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
67,819,183

Security key

09075A108

Report period

Q1 2022

Institutions

100

Top holders

10

Ownership snapshot

Top reported holders of BVS - Bioventus Inc. - Class A Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Essex Woodlands Managemen...
Disclosed value leader
Essex Woodlands Managemen...
Comparable rows
15/15
Latest evidence
31 Dec 2021
13F Lead comparable stake: 18% Showing 1-6 of 15 holder rows.

Quick read

Essex Woodlands Management, Inc. leads the comparable SEC ownership view at 18%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Essex Woodlands Management, Inc.'s linked filing trail.
Comparable ownership Top 5
Essex Woodlands Management, Inc. 18%
Juniper Investment Company, LLC 4.1%
BlackRock Finance, Inc. 2.7%
ROYCE & ASSOCIATES LP 2.6%
SV Health Investors, LLC 2.3%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Essex Woodlands Management, Inc.
13F
Company
13F
18%
$175,281,000
12,096,702 shares
31 Dec 2021
Juniper Investment Company, LLC
13F
Company
13F
4.1%
$39,822,000
2,748,207 shares
31 Dec 2021
BlackRock Finance, Inc.
13F
Company
13F
2.7%
$26,301,000
1,815,032 shares
31 Dec 2021
ROYCE & ASSOCIATES LP
13F
Company
13F
2.6%
$25,911,000
1,788,205 shares
31 Dec 2021
SV Health Investors, LLC
13F
Company
13F
2.3%
$22,909,000
1,581,031 shares
31 Dec 2021
VANGUARD GROUP INC
13F
Company
13F
2.3%
$22,553,000
1,556,429 shares
31 Dec 2021
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
100
Shares
31,706,911
Rows available
100
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2022 vs Q1 2022 Across Filers

Q1 2022 holders
100
Q1 2022 holders
100
Holder diff
0
Investor Q1 2022 Shares Q1 2022 Shares Share Diff Share Chg % Q1 2022 value Q1 2022 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .